Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
| Official URL: https://fevir.net/resources/EvidenceVariable/5269 | Version: 1.0.0-ballot3 | ||||
| Standards status: Informative | Computable Name: Percentage_of_Participants_With_Clinical_Recovery_Within_14_Days_After_Randomization_NCT04401202 | ||||
| Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#5269, FEvIR Linking Identifier: NCT04401202-primaryOutcome-0, OID:2.16.840.1.113883.4.642.40.44.24.169 | |||||
Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse). |
|||||
The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms)
version: 21; Last updated: 2026-08-05 07:33:36+0000
Profile: VariableDefinition
ArtifactPublicationStatus: Active
identifier: FEvIR Object Identifier/5269, FEvIR Linking Identifier/NCT04401202-primaryOutcome-0, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.24.169
version: 1.0.0-ballot3
name: Percentage_of_Participants_With_Clinical_Recovery_Within_14_Days_After_Randomization_NCT04401202
title: Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202)
citeAs:
Percentage of Participants With Clinical Recovery Within 14 Days After Randomization (NCT04401202) [Database Entry: FHIR EvidenceVariable Resource]. Contributors: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 5269. Revised 2026-08-05. Available at: https://fevir.net/resources/EvidenceVariable/5269. Computable resource at: https://fevir.net/resources/EvidenceVariable/5269#json.
status: Active
date: 2026-11-05 14:34:28+0000
author: Computable Publishing®: ClinicalTrials.gov-to-FEvIR Converter:
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms)
copyright:
Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).
| Concept |
| Percentage of Participants With Clinical Recovery Within 14 Days After Randomization The Percentage of patients who had clinical recovery within 14 days after randomization (clinical recovery was defined as three days of no symptoms) |
handling: Evidence variable handling not specified
| Text |
| Day 14 |